Bringing nanomedicines to market: regulatory challenges, opportunities, and uncertainties
Authors:
- Krishna BalakrishnanKBKrishna Balakrishnan
- 1 June 2006
- journal article
- review article
- Published by Elsevier in Nanomedicine: Nanotechnology, Biology and Medicine
- Vol. 2 (2) , 127-136
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Nanoparticle Albumin–Bound Paclitaxel for Metastatic Breast CancerJournal of Clinical Oncology, 2005
- Schweißen + SchraubenStahlbau, 2003
- Tumor Therapy with Targeted Atomic NanogeneratorsScience, 2001
- Antibacterial agents based on the cyclic d,l-α-peptide architectureNature, 2001
- New technologies in medicine: biotechnology and nanotechnologyDisease-a-Month, 1999